MainNumber of educational outreach meetings with Centers, Office of Regulatory Affairs, and District Offices in the monthOCI headquarters reaches out to the Centers in order to provide FDA information about OCI's role and responsibilities related to criminal investigations. Outreach includes an overview of OCI, discussion of the Staff Manual Guide and Regulatory Procedures Manual, requirements for the notification of OCI on criminal cases, discussion of the process by which OCI begins interaction with a US Attorney's Office.Numbercolumn01002010Measure was implemented starting September 1, 2010.FY 2010 Overall: 7901002011This measure was archived on April 30, 2011.FY 2011 YTD: 274MainNumber of outreach meetings with the Office of Regulatory Affairs in the monthOCI headquarters reaches out to the Office of Regulatory Affairs components in order to provide FDA information about OCI's role and responsibilities related to criminal investigations. Outreach includes an overview of OCI, discussion of the Staff Manual Guide and Regulatory Procedures Manual, requirements for the notification of OCI on criminal cases, discussion of the process by which OCI begins interaction with a US Attorney's Office. This outreach assists regulatory counterparts in identifying potential criminal activity related to FDA regulated products.Numbercolumn01002010Measure was implemented starting September 1, 2010.FY 2010 Overall: 2101002011This measure was archived on April 30, 2011.FY 2011 YTD: 83MainNumber of outreach meetings with District Offices in a monthThe OCI Field Offices reach out to the Office of Regulatory Affairs District Offices to educate the offices about OCI's role in protecting the public health to enhance case referrals and information sharing. This outreach also helps educate regulatory counterparts about identifying potential criminal activity related to FDA regulated products.Numbercolumn01002010Measure was implemented starting September 1, 2010.FY 2010 Overall: 5201002011This measure was archived on April 30, 2011.FY 2011 YTD: 182http://www.fda.gov/AboutFDA/Transparency/track/ucm204013.htmFDA-TRACK ORA Office of Dashboard